Evidence map›Paper›PMID 33316880›Full record

ArticleInternational journal of molecular sciences2020

Cell-free Stem Cell-Derived Extract Formulation for Regenerative Medicine Applications.

Ashim Gupta, Craig Cady, Anne-Marie Fauser, Hugo C Rodriguez, R Justin Mistovich, Anish G R Potty, Nicola Maffulli

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06608134 (Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for), which is not on this map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06608134 early_phase1recruitingnot on this mapstarted 2024, after this paper: background citation

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for

TypeinterventionalSponsorR3 Medical ResearchRan2024 to 2029Enrolled120ConditionsOsteoarthritis, KneeArmsUmbilical Cord Wharton's Jelly Allograft Intra-articular Knee Injection
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Effects of exosomes from different origins on osteoclasts.Journal of orthopaedic surgery and research · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Ashim GuptaGeneral Therapeutics, Cleveland Heights, OH 44118, USA.ORCID 0000-0003-1224-2755
Craig CadyGeneral Therapeutics, Cleveland Heights, OH 44118, USA.
Anne-Marie FauserBohlander Stem Cell Research Laboratory, Department of Biology, Bradley University, Peoria, IL 61625, USA.
Hugo C RodriguezFuture Biologics, Lawrenceville, GA 30043, USA.
R Justin MistovichGeneral Therapeutics, Cleveland Heights, OH 44118, USA.
Anish G R PottyGeneral Therapeutics, Cleveland Heights, OH 44118, USA.
Nicola MaffulliDepartment of Musculoskeletal Disorders, School of Medicine and Surgery, University of Salerno, 84084 Fisciano, Italy.ORCID 0000-0002-5327-3702
Bradley University · USCase Western Reserve University · USLaredo Community College · USUniversity of Salerno · ITUniversity of the Incarnate Word · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cells for regenerative medicine purposes offer therapeutic benefits, but disadvantages are still ill defined. The benefit of stem cells may be attributed to their secretion of growth factors (GFs), cytokines (CKs), and extracellular vesicles (EVs), including exosomes. We present a novel cell-free stem cell-derived extract (CCM), formulated from human progenitor endothelial stem cells (hPESCs), characterized for biologically active factors using ELISA, nanoparticle tracking analysis and single particle interferometric reflectance imaging sensing. The effect on fibroblast proliferation and ability to induce stem cell migration was analyzed using Alamar Blue proliferation and Transwell migration assays, respectively. GFs including IGFBP 1, 2, 3, and 6, insulin, growth hormone, PDGF-AA, TGF-α, TGF-β1, VEGF, and the anti-inflammatory cytokine, IL-1RA were detected. Membrane enclosed particles within exosome size range and expressing exosome tetraspanins CD81 and CD9 were identified. CCM significantly increased cell proliferation and induced stem cell migration. Analysis of CCM revealed presence of GFs, CKs, and EVs, including exosomes. The presence of multiple factors including exosomes within one formulation, the ability to promote cell proliferation and induce stem cell migration may reduce inflammation and pain, and augment tissue repair.

Indexed as

Cell ExtractsCell MovementCell ProliferationCells, CulturedCytokinesEndothelial Progenitor CellsExosomesFibroblastsHumansInsulinIntercellular Signaling Peptides and ProteinsTetraspaninsCell ExtractsCytokinesInsulinIntercellular Signaling Peptides and ProteinsTetraspaninscytokinesexosomesextracellular vesiclesgrowth factorsmusculoskeletal injuriesosteoarthritisprogenitor cellsregenerative medicinestem cells

Identifiers

PMID33316880
PMCPMC7763336
OpenAlexW3113277949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.